Literature DB >> 30797568

Pharmacoepidemiology in pregnancy.

Justine Benevent1, Mélanie Araujo2, Caroline Hurault-Delarue2, Jean-Louis Montastruc3, Agnès Sommet3, Isabelle Lacroix2, Christine Damase-Michel4.   

Abstract

Taking a medication is usually a challenge for a pregnant woman as the beneficial drug effect on the mother has to be considered regarding its potential adverse effects, not only for her but also for her unborn child. As medication use is common in pregnant women, by chance or necessity, it gives the opportunity to evaluate the consequences of prenatal drug exposure in real life through pharmacoepidemiological studies. This paper provides an overview of data sources, study designs and data analysis methods that can be used for pregnancy medication safety studies. In the future, the implementation of responsive international networks may be the keystones of drug evaluation in pregnancy.
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Data sources; Long-term effects; Pharmacoepidemiology; Pregnancy

Mesh:

Substances:

Year:  2019        PMID: 30797568     DOI: 10.1016/j.therap.2018.11.014

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  2 in total

1.  Chloroquine and hydroxychloroquine during pregnancy: What do we know?

Authors:  Isabelle Lacroix; Justine Bénévent; Christine Damase-Michel
Journal:  Therapie       Date:  2020-05-11       Impact factor: 2.070

2.  The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives.

Authors:  Valeria Belleudi; Filomena Fortinguerra; Francesca R Poggi; Serena Perna; Renata Bortolus; Serena Donati; Antonio Clavenna; Anna Locatelli; Marina Davoli; Antonio Addis; Francesco Trotta
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.